Zymeworks Inc. (ZYME)

USD 12.74

(-4.71%)

Revenue Summary of Zymeworks Inc.

Zymeworks Inc.'s latest annual revenue in 2023 was 76.01 Million USD , down -81.57% from previous year.
Zymeworks Inc.'s latest quarterly revenue in 2024 Q2 was 19.24 Million USD , up 91.85% from previous quarter.
Zymeworks Inc. reported a annual revenue of 412.48 Million USD in annual revenue 2022, up 1446.03% from previous year.
Zymeworks Inc. reported a annual revenue of 26.68 Million CAD in annual revenue 2021, down -31.5% from previous year.
Zymeworks Inc. reported a quarterly revenue of 10.03 Million USD for 2024 Q1, down -40.74% from previous quarter.
Zymeworks Inc. reported a quarterly revenue of 16 Million USD for 2024 Q3, down -16.85% from previous quarter.

Annual Revenue Chart of Zymeworks Inc. (2023 - 2014)

Historical Annual Revenue of Zymeworks Inc. (2023 - 2014)

Year	Revenue	Revenue Growth
2023	76.01 Million USD	-81.57%
2022	412.48 Million USD	1446.03%
2021	26.68 Million CAD	-31.5%
2020	38.95 Million USD	31.84%
2019	29.54 Million USD	-44.28%
2018	53.01 Million USD	2.43%
2017	51.76 Million USD	370.18%
2016	11 Million USD	13.96%
2015	9.66 Million USD	478.44%
2014	1.67 Million USD	0.0%

Year	Revenue	Revenue Growth
2024 Q2	19.24 Million USD	91.85%
2024 Q1	10.03 Million USD	-40.74%
2024 Q3	16 Million USD	-16.85%
2023 Q3	16.5 Million USD	135.73%
2023 Q1	35.57 Million USD	-91.16%
2023 Q2	7 Million USD	-80.32%
2023 FY	76.01 Million USD	-81.57%
2023 Q4	16.92 Million USD	2.54%
2022 Q2	5.44 Million USD	184.03%
2022 FY	412.48 Million USD	1446.03%
2022 Q4	402.49 Million USD	15198.1%
2022 Q3	2.63 Million USD	-51.65%
2022 Q1	1.91 Million USD	-90.36%
2021 Q4	19.87 Million CAD	352.1%
2021 Q2	1.77 Million USD	175.0%
2021 FY	26.68 Million CAD	-31.5%
2021 Q1	644 Thousand USD	-95.89%
2021 Q3	4.39 Million USD	148.16%
2020 Q2	12.35 Million USD	49.46%
2020 Q1	8.26 Million USD	340.54%
2020 Q4	15.68 Million USD	493.27%
2020 FY	38.95 Million USD	31.84%
2020 Q3	2.64 Million USD	-78.61%
2019 Q1	11.92 Million USD	-58.77%
2019 FY	29.54 Million USD	-44.28%
2019 Q4	1.87 Million USD	-76.12%
2019 Q3	7.86 Million USD	-0.28%
2019 Q2	7.88 Million USD	-33.9%
2018 Q3	2.05 Million USD	-90.66%
2018 Q4	28.92 Million USD	1308.23%
2018 FY	53.01 Million USD	2.43%
2018 Q1	40 Thousand USD	-99.92%
2018 Q2	22 Million USD	54900.0%
2017 Q1	230 Thousand USD	-89.7%
2017 Q2	1.34 Million USD	483.48%
2017 Q3	119 Thousand USD	-91.13%
2017 Q4	50.07 Million USD	41976.47%
2017 FY	51.76 Million USD	370.18%
2016 Q3	2.17 Million USD	-65.76%
2016 Q2	6.34 Million USD	2320.99%
2016 Q1	262 Thousand USD	-81.79%
2016 FY	11 Million USD	13.96%
2016 Q4	2.23 Million USD	2.76%
2015 FY	9.66 Million USD	478.44%
2015 Q4	1.43 Million USD	0.0%
2014 FY	1.67 Million USD	0.0%

Peer Revenue Comparison of Zymeworks Inc.

Name	Revenue	Revenue Difference
ADC Therapeutics SA	69.55 Million USD	-9.279%
Alto Neuroscience, Inc.	- USD	-Infinity%
Annovis Bio, Inc.	- USD	-Infinity%
Biohaven Pharmaceutical Holding Company Ltd.	- USD	-Infinity%
Ginkgo Bioworks Holdings, Inc.	251.45 Million USD	69.771%
Nuvation Bio Inc.	- USD	-Infinity%
Nuvation Bio Inc.	- USD	-Infinity%
Arcus Biosciences, Inc.	117 Million USD	35.032%
Theriva Biologics, Inc.	- USD	-Infinity%